Increased levels of soluble vascular endothelial cadherin are associated with poor outcome in severe sepsis

Journal of International Medical Research

Volumn 38, Issue 4, 2010, Pages 1497-1506

  Zhang, R Y ^a   Liu, Y Y ^a   Li, L ^a   Cui, W ^a   Zhao, K J ^a   Huang, W C ^a   Gu, X W ^a   Liu, W ^a   Wu, J ^a   Min, D ^a   Mao, E Q ^a   Tang, Y Q ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Endothelial dysfunction; Severe sepsis; Soluble marker; Ve cadherin

Indexed keywords

CREATININE; LACTIC ACID; VASCULAR ENDOTHELIAL CADHERIN;

ADULT; AGED; ARTICLE; CELL ADHESION; CELL DAMAGE; CELL FUNCTION; CELL JUNCTION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE DURATION; DISEASE SEVERITY; DOWN REGULATION; ENDOTHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IN VITRO STUDY; INTENSIVE CARE UNIT; LACTATE BLOOD LEVEL; LENGTH OF STAY; LEUKOCYTE COUNT; MALE; MULTIPLE ORGAN FAILURE; PATHOGENESIS; PROGNOSIS; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SEPSIS; UMBILICAL VEIN; UPREGULATION; WESTERN BLOTTING;

EID: 77957742378     PISSN: 03000605     EISSN: None     Source Type: Journal    
DOI: 10.1177/147323001003800433     Document Type: Article

References (24)

1. Martin GS, Mannino DM, Eaton S, et al: The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 2003; 348: 1546-1554.
2. Dombrovskiy VY, Martin AA, Sunderram J, et al: Rapid increase in hospitalization and mortality rates for severe sepsis in the United States: a trend analysis from 1993 to 2003. Crit Care Med 2007; 35: 1244-1250.
3. Dellinger RP, Levy MM, Carlet JM, et al: Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 2008; 36: 296-327.
4. Hack CE, Zeerleder S: The endothelium in sepsis: source of and a target for inflammation. Crit Care Med 2001; 29(7 suppl): S21-S27.
5. Vallet B: Bench-to-bedside review: endothelial cell dysfunction in severe sepsis: a role in organ dysfunction? Crit Care 2003; 7: 130-138.
6. Aird WC: The role of the endothelium in severe sepsis and multiple organ dysfunction syndrome. Blood 2003; 101: 3765-3777.
7. Aird WC: Endothelium as a therapeutic target in sepsis. Curr Drug Targets 2007; 8: 501-507.
8. Pober JS, Sessa WC: Evolving functions of endothelial cells in inflammation. Nat Rev Immunol 2007; 7: 803-815.
9. Lampugnani MG, Resnati M, Raiteri M, et al: A novel endothelial-specific membrane protein is a marker of cell-cell contacts. J Cell Biol 1992; 118: 1511-1522.
10. Dejana E, Orsenigo F, Lampugnani MG: The role of adherens junctions and VE-cadherin in the control of vascular permeability. J Cell Sci 2008; 121: 2115-2122.
11. Corada M, Mariotti M, Thurston G, et al: Vascular endothelial-cadherin is an important determinant of microvascular integrity in vivo. Proc Natl Acad Sci USA 1999; 96: 9815-9820.
12. Beckers CM, García-Vallejo JJ, van Hinsbergh VW, et al: Nuclear targeting of β-catenin and p120ctn during thrombin-induced endothelial barrier dysfunction. Cardiovasc Res 2008; 79: 679-688.
13. Taddei A, Giampietro C, Conti A, et al: Endothelial adherens junctions control tight junctions by VE-cadherin-mediated upregulation of claudin-5. Nat Cell Biol 2008; 10: 923-934.
14. Sulkowska M, Famulski W, Wincewicz A, et al: Levels of VE-cadherin increase independently of VEGF in preoperative sera of patients with colorectal cancer. Tumori 2006; 92: 67-71.
15. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992; 20: 864-874.
16. Knaus WA, Draper EA, Wagner DP, et al: APACHE II: a severity of disease classification system. Crit Care Med 1985; 13: 818-829.
17. Villasante A, Pacheco A, Pau E, et al: Soluble vascular endothelial-cadherin levels correlate with clinical and biological aspects of severe ovarian hyperstimulation syndrome. Hum Reprod 2008; 23: 662-667.
18. Ha CH, Bennett AM, Jin ZG: A novel role of vascular endothelial cadherin in modulating c-Src activation and downstream signaling of vascular endothelial growth factor. J Biol Chem 2008; 283: 7261-7270.
19. Müller AM, Gruhn KM, Herwig MC, et al: VEcadherin and ACE: markers for sepsis in post mortem examination? Leg Med (Tokyo) 2008; 10: 257-263.
20. Nakamura T, Ebihara I, Shimada N, et al: Modulation of plasma metalloproteinase-9 concentrations and peripheral blood monocyte mRNA levels in patients with septic shock: effect of fiber-immobilized polymyxin B treatment. Am J Med Sci 1998; 316: 355-360.
21. Navaratna D, McGuire PG, Menicucci G, et al: Proteolytic degradation of VE-cadherin alters the blood-retinal barrier in diabetes. Diabetes 2007; 56: 2380-2387.
22. Ryniers F, Stove C, Goethals M, et al: Plasmin produces an E-cadherin fragment that stimulates cancer cell invasion. Biol Chem 2002; 383: 159-165.
23. Noe V, Fingleton B, Jacobs K, et al: Release of an invasion promoter E-cadherin fragment by matrilysin and stromelysin-1. J Cell Sci 2001; 114: 111-118.
24. Baumgartner W, Schutz GJ, Wiegand J, et al: Cadherin function probed by laser tweezer and single molecule fluorescence in vascular endothelial cells. J Cell Sci 2003; 116: 1001-1011.